
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Syneos Health DPO 2011-2026 | SYNH
DPO Jährlich Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.1 | - | 13.7 | 10.5 | 10.4 | 7.17 | 8 | 6.83 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 13.7 | 6.83 | 9.53 |
DPO Vierteljährlich Syneos Health
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.1 | - | - | - | 9.43 | - | 9.64 | 10.2 | 11 | - | 12.7 | 12.9 | 12.4 | - | 13.7 | 13.6 | 12.1 | - | 10.3 | 10.6 | 8.53 | - | - | 18.1 | 13.2 | - | 7.41 | 7.2 | 6.67 | - | 8.17 | 8.28 | 7.99 | - | 6.85 | 7.09 | 5.88 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18.1 | 5.88 | 10.2 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
125 | $ 16.25 | 0.06 % | $ 171 M | ||
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 20.65 | -0.75 % | $ 1.1 B | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 1.65 | 7.84 % | $ 2.19 M | ||
|
Agilent Technologies
A
|
50.1 | $ 113.95 | 2.38 % | $ 34.6 B | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 15.07 | 1.82 % | $ 456 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 24.54 | 1.24 % | $ 682 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 115.88 | -0.25 % | $ 9.56 B | ||
|
Illumina
ILMN
|
56.3 | $ 125.86 | 4.56 % | $ 20 B | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 164.61 | 0.47 % | $ 8.16 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
48.6 | $ 84.55 | 1.37 % | $ 10.6 B | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 81.81 | 0.79 % | $ 5.52 B | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 416.27 | 0.65 % | $ 12 B | ||
|
NeoGenomics
NEO
|
19.7 | $ 9.11 | 1.62 % | $ 1.17 B | ||
|
National Research Corporation
NRC
|
10.1 | $ 16.4 | -0.85 % | $ 367 M | ||
|
Personalis
PSNL
|
67.3 | $ 5.16 | 2.28 % | $ 306 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Senseonics Holdings
SENS
|
68 | $ 6.24 | -2.88 % | $ 260 M | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.16 | - | $ 4.96 M | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 475.17 | 1.91 % | $ 179 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 264.03 | 2.68 % | $ 22 B | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.62 | 3.33 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 58.32 | 2.86 % | $ 3.49 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.28 | 2.94 % | $ 2.01 B | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.75 | 1.39 % | $ 440 M | ||
|
OpGen
OPGN
|
95 | - | -16.95 % | $ 1.54 M | ||
|
Natera
NTRA
|
17.9 | $ 200.62 | 3.01 % | $ 19.7 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 195.73 | 3.36 % | $ 21.7 B |